Seroprevalence of herpes simplex virus type 2 in multiple sclerosis

Acta Neurologica Scandinavica

Volumn 114, Issue 6, 2006, Pages 363-367

  Hawkes, C H ^a   Giovannoni, G ^b   Keir, G ^b   Cunnington, M ^c   Thompson, E J ^b  

^a OLDCHURCH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Herpes simplex virus type 2; Multiple sclerosis; Seroprevalence

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION RATE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; SAMPLE SIZE; SEROPREVALENCE; SEX RATIO;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; FEMALE; GREAT BRITAIN; HERPESVIRUS 2, HUMAN; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS;

EID: 33750624139     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00677.x     Document Type: Article

References (20)

1. KURTZKE JF, HELTBERG A. Multiple sclerosis in the Faroe Islands: an epitome. J Clin Epidemiol 2001;54:1-22.
2. DEAN G, KURTZKE JF. On the risk of multiple sclerosis according to age at immigration to South Africa. Br Med J 1971;3:725-9.
3. COWAN FM, COPAS A, JOHNSON AM, ASHLEY R, COREY L, MINDEL A. Herpes simplex virus type 1 infection: a sexually transmitted infection of adolescence? Sex Transm Infect 2002;78:346-8.
4. MARTIN JR. Spinal cord and optic nerve demyelination in experimental herpes simplex virus type 2 infection. J Neuropathol Exp Neurol 1982;41:253-66.
5. MARTIN JR. Herpes simplex virus types 1 and 2 and multiple sclerosis. Lancet 1981;2:777-81.
6. MAYR WT, PITTOCK SJ, MCCLELLAND RL, JORGENSEN NW, NOSEWORTHY JH, RODRIGUEZ M. Incidence and prevalence of multiple sclerosis in Olmsted County, Minnesota, 1985-2000. Neurology 2003;61:1373-7.
7. FERRANTE P, CASTELLANI P, BARBI M, BERGAMINI F. The Italian Cooperative Multiple Sclerosis case-control study: preliminary results on viral antibodies. Ital J Neurol Sci 1987;6(Suppl.):45-50.
8. FERRANTE P, MANCUSO R, PAGANI E et al. Molecular evidences for a role of HSV-1 in multiple sclerosis clinical acute attack. J Neurovirol 2000;6(Suppl. 2):S109-14.
9. SANDERS VJ, WADDELL AE, FELISAN SL, LI X, CONRAD AJ, TOURTELLOTTE WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 1996;53:125-33.
10. COWAN FM, JOHNSON AM, ASHLEY R, COREY L, MINDEL A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. Br Med J 1994;309:1325-9.
11. ADES AE, PECKHAM CS, DALE GE, BEST JM, JEANSSON S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989;43:53-60.
12. COWAN FM, JOHNSON AM, WADSWORTH J, BRENNAN M. Behavioural risk factors for HIV infection amongst blood donors in London. Transfus Med 1996;6:31-6.
13. VYSE AJ, GAY NJ, SLOMKA MJ et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000;76:183-7.
14. POSER CM, PATY DW, SCHEINBERG L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
15. MORRIS-CUNNINGTON MC, BROWN DWG, PIMENTA J M, ROBINSON NJ, MILLER E. New estimates of HSV-2 seroprevalence in England: "high" but stable seroprevalence over the last decade. Sex Transm Dis 2004;31:243-6.
16. GOPAL R, GIBBS T, SLOMKA MJ et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody: validation for seroepidemiological studies in Africa. J Virol Methods 2000;87:71-80.
17. EING BR, LIPPELT L, LORENTZEN EU et al. Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2. J Clin Microbiol 2002;40:407-13.
18. WALD A, ASHLEY-MORROW R. Serological testing for herpes simplex virus (HSV)-1 and HSV-2 infection. Clin Infect Dis 2002;35(Suppl. 2):S173-82.
19. EBERS GC, YEE IM, SADOVNICK AD, DUQUETTE P. Conjugal multiple sclerosis: population-based prevalence and recurrence risks in offspring. Canadian Collaborative Study Group. Ann Neurol 2000;48:927-31.
20. HAWKES C. Conjugal multiple sclerosis. Ann Neurol 2001;50:552-3.